Skip to content
Disclosery

Casdin Capital, LLC: MRNA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Casdin Capital, LLC on MRNA, newest first. How the timeline and the estimate are built.

Casdin Capital, LLC held 75,000 MRNA shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 75,000 shares
    Change vs previous 13F 0 shares

    0.26% of the 13F portfolio, value $5,252,250.

    13F-HR 0000919574-26-005491 filed by Casdin Capital, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 75,000 shares
    Change vs previous 13F +75,000 shares

    0.29% of the 13F portfolio, value $3,810,000.

    13F-HR 0000919574-26-003451 filed by Casdin Capital, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 0 shares
    Change vs previous 13F -225,000 shares

    13F-HR 0000919574-25-004903 filed by Casdin Capital, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  4. period ended2025-03-31
    13F 225,000 shares
    Change vs previous 13F +50,000 shares

    0.52% of the 13F portfolio, value $6,378,750.

    13F-HR 0000919574-25-003248 filed by Casdin Capital, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-12-31
    13F 175,000 shares
    Change vs previous 13F not available

    0.49% of the 13F portfolio, value $7,276,500.

    13F-HR 0000919574-25-001518 filed by Casdin Capital, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).